Analysed GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS) News Sources
Galderma’s Restylane® Volyme™ Demonstrates High Effectiveness, Satisfaction and a Robust Safety Profile in Chinese Patients With Temple Hollowing
16-09-2026
yahoo.com
Galderma Begins Trading in the Swiss Market Index, Joining Switzerland's Leading Blue Chip Companies
21-09-2026
yahoo.com
EADV 2026: Galderma to Unveil New Data Advancing Understanding of Skin Diseases, Skin Longevity, and Real-world Patient Experiences
23-09-2026
yahoo.com
EADV 2026: Galderma’s New Data Show Sustained Improvements with Nemluvio® (nemolizumab) for up to Three Years in Patients With Moderate-to-severe Atopic Dermatitis
30-09-2026
yahoo.com
30 Years of Restylane®: Reshaping the Aesthetics Field Through Science-Led, Patient-Centric Innovation
06-10-2026
yahoo.com
Fall Clinical 2026: Galderma Presents New Three-Year Nemluvio® Data Showing Deep and Lasting Skin Lesion and Itch Responses in Patients With Atopic Dermatitis Aged 12 and Older
08-10-2026
yahoo.com
What is the current price of GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS)?
The current price of GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS) is $39.79.
GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS) absolute price change since previous trading day?
The absolute price change of GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS) since the previous trading day is $0.42.
GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS) percentage price change since previous trading day?
The percentage price change of GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS) since the previous trading day is 1.0668%.
What is the most recent average sentiment score for GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS)?
The most recent average sentiment score for GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS) is 79 out of 100.
What is the most recent average sentiment for GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS)?
The most recent sentiment for GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS) is .
SEC-8K** Filing Available For GALDERMA GROUP AG-UNSPON ADR (GALDY:OTCMKTS)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.